Sichuan Biokin Pharmaceutical Co., Ltd. Class ASSE: 688506

Announcement on Convening the 2025 Annual Collective Performance Briefing for Biological Products Industry on SSE STAR Market and the Q1 2026 Performance Briefing

· Issued by Sichuan Biokin Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Annual Collective Performance Briefing for Biological Products Industry on SSE STAR Market and the Q1 2026 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis